Sana Biotechnology, Inc.
Key Metrics
- Previous Close
- $4.10
- 52-Week Range
- $2.61 – $6.55
- Market Cap
- $1.12B
- P/E (TTM)
- —
- EPS (TTM)
- -0.68
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- 8.46
- PEG Ratio
- —
- Return on Equity
- -152.87%
- Return on Assets
- -29.16%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 1.38
- Debt/Equity
- 0.52
- Total Debt
- $80.94M
- Free Cash Flow
- $4.13M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $1.04B
Market Snapshot
About
Sana Biotechnology is a clinical-stage biotechnology company focused on developing engineered cell therapies. The company works on creating and delivering engineered cells as medicines for patients, with programs targeting blood cancers, solid tumors, autoimmune diseases, and genetic disorders. Sana is developing hypoimmune cell platforms designed to reduce or eliminate the need for immunosuppression.